Rigel Pharmaceuticals, Inc. (RIGL)
35.46
-1.18
(-3.22%)
USD |
NASDAQ |
Feb 20, 16:00
35.45
-0.01
(-0.03%)
Pre-Market: 20:00
Rigel Pharmaceuticals Market Cap : 643.65M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 1.276B |
| Eli Lilly & Co. | 952.34B |
| Ironwood Pharmaceuticals, Inc. | 644.21M |
| BioMarin Pharmaceutical, Inc. | 12.31B |
| Catalyst Pharmaceuticals, Inc. | 2.987B |
Market Cap Related Metrics
| PE Ratio | 5.751 |
| PS Ratio | 2.309 |
| PEG Ratio | 0.0021 |
| Price to Book Value | 5.473 |
| Price to Free Cash Flow | 9.559 |
| Price | 35.46 |
| Earnings Yield | 17.39% |
| PEGY Ratio | 0.0021 |
| Operating PE Ratio | 5.476 |
| Normalized PE Ratio | 5.751 |